




Healthcare Industry News: ear tubes
News Release - January 6, 2022
New Procedure to Revolutionise Paediatric Ear Surgery Performed for the First Time with AventaMed Solo + Tympanostomy Tube Device (TTD)
CORK, Ireland, Jan. 6, 2022 -- (Healthcare Sales & Marketing Network) -- AventaMed DAC, a developer of novel medical devices that streamline surgery, allowing procedures to move out of the operating theatre and into new sites of service such as the doctor's office or clinic, announced the first use of its Solo+ TTD in a paediatric patient while the patient was awake. The procedure was performed by Dr. Joćo Pimentel, a prominent otorhinolaryngologist specialist in Lisbon, Portugal at Hospital da Luz Oeiras.Keith Jansen, President and CEO of AventaMed, commented, "This is a huge step forward for the company to be able to help doctors treat children who require ear tubes. The insertion of ear tubes is the most frequently performed surgical procedure on children. Millions of procedures are performed around the world each year. The Solo+ enables doctors to offer patients' families a very significant alternative to what has been performed until now. More and more different types of procedures are being done in an ambulatory setting. Solo+ enables ear tube placements to be done there as well. This should also mean that significant cost savings can be realised for the payers of these procedures."
Dr. Pimentel added, "It is a significant benefit for patients to be able to immediately return to normal activities. Patients, and their families, no longer must wait in a hospital for a prolonged period of time while the patient is prepared for surgery and then recovers from the general anaesthesia. As a result, parents can also return to their normal activities immediately."
About AventaMed
AventaMed seeks to provide a higher standard of care for the most-frequently performed paediatric surgery in a safer, faster, more cost-effective manner while improving the patient / family experience in a sustainable way.
Source: AventaMed
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.